We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGG
126
DELISTED
Vy Global Growth
VYGG
$1.52M 0.23%
150,000
-149,990
-50% -$1.66M
SPGS.U
127
DELISTED
Simon Property Group Acquisition Holdings, Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
SPGS.U
$1.51M 0.23%
+150,000
New +$1.54M
BFLY.WS
128
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$1.5M 0.23%
+233,332
New +$1.9M
ANZUU
129
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
$1.5M 0.23%
+150,000
New +$1.5M
FCAC
130
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
$1.5M 0.23%
149,994
LCAHU
131
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
$1.49M 0.23%
+150,000
New +$1.49M
BGSX.U
132
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
$1.48M 0.23%
+150,000
New +$1.48M
TWCT
133
DELISTED
TWC Tech Holdings II Corp. Class A Common Stock
TWCT
$1.48M 0.23%
149,997
RCEL icon
134
Avita Medical
RCEL
$235M
$1.47M 0.23%
+74,229
New +$1.73M
OEPW
135
DELISTED
One Equity Partners Open Water I Corp. Class A Common Stock
OEPW
$1.46M 0.23%
+149,991
New +$1.46M
NVEE
136
DELISTED
NV5 Global
NVEE
$1.45M 0.22%
+60,000
New +$1.43M
ADMS
137
DELISTED
Adamas Pharmaceuticals
ADMS
$1.44M 0.22%
+300,000
New +$1.57M
CMAX
138
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.43M 0.22%
3,940
ASLN
139
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.41M 0.22%
+10,500
New +$1.33M
PWP icon
140
Perella Weinberg Partners
PWP
$1.26B
$1.4M 0.22%
+125,000
New +$1.4M
PHAS
141
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$1.38M 0.21%
+400,000
New +$1.62M
ML
142
DELISTED
MoneyLion Inc.
ML
$1.38M 0.21%
4,629
-2,038
-31% -$680K
SMTI icon
143
Sanara MedTech
SMTI
$315M
$1.37M 0.21%
+44,060
New +$1.53M
ENVX icon
144
Enovix
ENVX
$1.01B
$1.33M 0.2%
+114,286
New +$1.5M
XRN
145
Chiron Real Estate Inc
XRN
$475M
$1.31M 0.2%
+20,000
New +$1.33M
BIDU icon
146
Baidu
BIDU
$37.1B
$1.3M 0.2%
+6,000
New +$1.57M
HTO
147
H2O America
HTO
$2.56B
$1.29M 0.2%
+20,474
New +$1.34M
IACA
148
DELISTED
ION Acquisition Corp 1 Ltd.
IACA
$1.26M 0.19%
124,990
CLIM.U
149
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CLIM.U
$1.25M 0.19%
+125,000
New +$1.37M
PRDS
150
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.25M 0.19%
+125,000
New +$1.29M

Similar funds

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.